SpectraScience has acquired the assets of Applied Materials-backed oncology diagnostics technology developer Oncoscope for an undisclosed sum.

Rani, which has created a process to convert injectable drugs into pills, has attracted capital from investors including AstraZeneca and Ping An, boosting its total funding to $70m.

GV has supported the initial tranche of a $75m series A round for Forty Seven, an immuno-oncology spinout of Stanford University.

GV has supported the initial tranche of a $75m series A round for Forty Seven, an immuno-oncology spinout of Stanford University.

Lilly Asia Ventures contributed funds to a $10m series B round for Impact Therapeutics, having previously participated in the company's 2014 series A.

Corporates remained active as crossover investors helped take healthcare VC investment to its highest level since 2000, Jonathan Norris of Silicon Valley Bank told Global Corporate Venturing.

The round has been extended to $56m following a $40m first close in December 2015 featuring GlaxoSmithKline, Novartis, Astellas and AbbVie.